Physician profile
Lillian Schapiro
NPI 1649289331
$2,438.11
in general payments reported to CMS, 2019-2025
28 companies · $345 in 2025
The $345 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $36.81 · 2021: $241 · 2022: $327 · 2023: $639 · 2024: $538 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,447 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,446.63 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $491.21 | 2019-2025 | Lo Loestrin Fe |
| Astellas Pharma US INC | $262.34 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $258.21 | 2021-2025 | |
| Evofem Biosciences, INC. | $164.79 | 2022-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $139.91 | 2022-2025 | Slynd |
| Aspira Women'S Health INC | $132.33 | 2022-2023 | Ova1 |
| Exact Sciences Corporation | $117.22 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $112.99 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $87.32 | 2019-2024 | |
| Coopersurgical, INC. | $80.77 | 2023-2025 | Wallach Cryosurgical Equipment, Mara Console |
| Intuitive Surgical, INC. | $78.69 | 2023 | Da Vinci Surgical System |
| Daiichi Sankyo INC. | $52.80 | 2022-2023 | Injectafer |
| Channel Medsystems, INC. | $49.99 | 2022 | |
| Pfizer INC. | $49.10 | 2022-2024 | |
| Therapeuticsmd, INC. | $48.17 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $46.44 | 2024-2025 | |
| Lilly USA, LLC | $37.15 | 2024-2025 | Zepbound |
| Conmed Corporation | $29.43 | 2023 | Airseal |
| Sumitomo Pharma America, INC. | $25.62 | 2023 | Myfembree |
| Abbott Laboratories | $22.37 | 2025 | Proclaim |
| Solta Medical, A Division of Bausch Health US, LLC | $21.57 | 2019 | |
| Phadia US INC. | $21.55 | 2022 | |
| Agile Therapeutics, INC. | $20.58 | 2022 | |
| Hologic Sales and Service, LLC | $19.96 | 2025 | Aptima |
| Roche Diagnostics Corporation | $19.69 | 2019 | |
| Medtronic, INC. | $19.02 | 2021 | |
| Mylan Pharmaceuticals INC. | $17.11 | 2021 | |
| Avion Pharmaceuticals | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Schapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.